Skip to main content

Y-mAbs Therapeutics Inc. Common Stock (YMAB)

About The Company

YMAB Stock Market Logo

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others.

IPO Year Sector Industry
2018 Health Care Biotechnology: Pharmaceutical Preparations

Y-mAbs Therapeutics Inc. (YMAB) Latest News

Company Contact & Address (YMAB)

Corporate Headquarters Phone Website
230 PARK AVENUE SUITE 3350,
NEW YORK,
New York,
10169,
United States
+1 646 885-8505 Official YMAB Website

YMAB Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ YMAB

Jobs & Employment at Y-mAbs Therapeutics Inc.

LinkedIn Company Page https://www.linkedin.com/company/y-mabs-therapeutics-inc-
Official Career & Employment Page Employment, Careers & Jobs at Y-mAbs Therapeutics Inc. (YMAB)

Related & Similar Stock Symbols

WRK Stock Market Price & News

WRK

Westrock Company Common Stock

DHCNL Stock Market Price & News

DHCNL

Diversified Healthcare Trust 6.25% Senior Notes Due 2046

COMS Stock Market Price & News

COMS

ComSovereign Holding Corp. Common Stock